Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 39 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 42 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 18 |
| Jul 2026 | 0 | 20 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 09, 2024 Filed Jan 10, 2024 21:06 UTC |
Golden Lee ScottCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 1,225 | $29.01 | $35,543.13 |
DisclosureSEC source: 0001415889-24-000913 · form4-01102024_090125.xml · nonDerivative · entry 2 Golden Lee Scott · CIK 0001686217 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,914 F3 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 990 RSUs from a January 6, 2021 grant of 3,960 RSUs and the vesting of 3,539 RSUs from January 7, 2022 grants totaling14,155 RSUs. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:04 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 1,938 | $29.01 | $56,230.68 |
DisclosureSEC source: 0001415889-24-000910 · form4-01102024_090136.xml · nonDerivative · entry 2 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,983 F2 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:03 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 100 | $29.01 | $2,901.48 |
DisclosureSEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 3,734 F6 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 150 RSUs from a January 6, 2021 grant of 600 RSUs and the vesting of 195 RSUs from a January 7, 2022 grant of 780 RSUs. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:03 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 1,521 | $29.01 | $44,131.51 |
DisclosureSEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,820 F5 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:11 UTC |
Utter Christine MarieSVP, FINANCE & CAO
|
SaleCommon Stock | 1,188 | $28.64 | $34,024.68 |
DisclosureSEC source: 0001415889-24-000921 · form4-01102024_090117.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,499 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 5, 2023 grant of 14,000 RSUs. F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:10 UTC |
SCHMERTZLER MICHAELDirector
|
SaleCommon Stock | 1,500 | $27.81 | $41,715.00 |
DisclosureSEC source: 0001415889-24-000919 · form4-01102024_090117.xml · nonDerivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,266 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023, to satisfy tax obligations in connection with the vesting of 4,664 restricted stock units from a January 5, 2023 grant of 8,000 restricted stock units. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:09 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 1,569 | $28.64 | $44,936.63 |
DisclosureSEC source: 0001415889-24-000917 · form4-01102024_090157.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,612 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 5, 2023 grant of 18,000 RSUs. F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:08 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 2,237 | $28.64 | $64,068.35 |
DisclosureSEC source: 0001415889-24-000915 · form4-01102024_090152.xml · nonDerivative · entry 1 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,918 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:06 UTC |
Golden Lee ScottCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 775 | $28.64 | $22,196.23 |
DisclosureSEC source: 0001415889-24-000913 · form4-01102024_090125.xml · nonDerivative · entry 1 Golden Lee Scott · CIK 0001686217 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,139 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,666 RSUs from a January 5, 2023 grant of 10,640 RSUs. F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:04 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 1,457 | $28.64 | $41,728.92 |
DisclosureSEC source: 0001415889-24-000910 · form4-01102024_090136.xml · nonDerivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,921 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:03 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 53 | $28.64 | $1,517.94 |
DisclosureSEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 3,834 F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs. F4 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:03 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 1,236 | $28.64 | $35,399.41 |
DisclosureSEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,341 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs. F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:29 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 10,107 | $27.15 | $274,392.92 |
DisclosureSEC source: 0001415889-24-000854 · form4-01092024_090130.xml · nonDerivative · entry 1 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,155 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs. F2 · balance_after: Includes 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023. Read SEC document |
| December 28, 2023 Filed Dec 28, 2023 22:12 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016992 · form4-12282023_101229.xml · nonDerivative · entry 1 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,961 F1 · shares: Restricted stock unit granted on December 28, 2023 that vests in four equal installments over four years, commencing on December 29, 2023. F2 · balance_after: Includes 316 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:38 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 7,700 | $25.81 | $198,736.23 |
DisclosureSEC source: 0001415889-23-016478 · form4-12142023_091224.xml · nonDerivative · entry 1 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,700 F1 · price: This price represents the weighted average price of purchase transactions that were executed in multiple trades at prices ranging from $25.77 to $25.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:02 UTC |
Young AlethiaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,666 | $27.85 Strike: $27.85 | $129,948.10 |
DisclosureSEC source: 0001415889-23-013116 · form4-09082023_080934.xml · derivative · entry 6 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,334 Underlying: Common Stock · 4,666 shares Expires 2032-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022 Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:02 UTC |
Young AlethiaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $27.85 Strike: $27.85 | $194,950.00 |
DisclosureSEC source: 0001415889-23-013116 · form4-09082023_080934.xml · derivative · entry 5 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2032-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:02 UTC |
Young AlethiaDirector
|
SaleCommon Stock | 4,666 | $39.79 | $185,672.27 |
DisclosureSEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 4 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,067 F1 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:02 UTC |
Young AlethiaDirector
|
Exercise / conversionCommon Stock | 4,666 | $27.85 | $129,948.10 |
DisclosureSEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 3 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:02 UTC |
Young AlethiaDirector
|
SaleCommon Stock | 7,000 | $39.90 | $279,300.00 |
DisclosureSEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 2 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,067 Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:02 UTC |
Young AlethiaDirector
|
Exercise / conversionCommon Stock | 7,000 | $27.85 | $194,950.00 |
DisclosureSEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 1 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:51 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $39.82 | $0.00 |
DisclosureSEC source: 0001415889-23-011167 · form4-07172023_080747.xml · derivative · entry 2 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2033-07-12 F2 · derivative.exercise_date: This option was granted on July 13, 2023, and vests over four years, with 25% of the shares underlying the option vesting on July 13, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 13, 2024. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:51 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011167 · form4-07172023_080747.xml · nonDerivative · entry 1 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 F1 · shares: Restricted stock units granted on July 13, 2023 that vest in four equal installments over four years, commencing on July 13, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:03 UTC |
SCHMERTZLER MICHAELDirector
|
SaleCommon Stock | 1,000 | $44.86 | $44,860.00 |
DisclosureSEC source: 0001415889-23-009501 · form4-06092023_080626.xml · nonDerivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,766 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023, to satisfy tax obligations in connection with the vesting of 3,334 restricted stock units from a January 5, 2023 grant of 8,000 restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC |
Bell William F. Jr.Director
|
GrantStock Option (Right to Buy) · Derivative | 5,834 | $0.00 Strike: $45.02 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · derivative · entry 4 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2033-06-05 F4 · derivative.exercise_date: This option was granted on June 6, 2023 and vests over seven approximately equal monthly installments, commencing on July 5, 2023. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC |
Bell William F. Jr.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $45.02 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · derivative · entry 3 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-05 F3 · derivative.exercise_date: This option was granted on June 6, 2023 and vests over thirty-six approximately equal monthly installments, commencing on July 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC |
Bell William F. Jr.Director
|
GrantCommon Stock | 2,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · nonDerivative · entry 2 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,333 F2 · shares: Restricted stock units granted on June 6, 2023 that vest on January 5, 2024. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC |
Bell William F. Jr.Director
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · nonDerivative · entry 1 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Restricted stock units granted on June 6, 2023 that vest in three equal installments over three years, commencing on June 6, 2024. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,402 | $33.63 Strike: $33.63 | $47,149.26 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 18 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,650 Underlying: Common Stock · 1,402 shares Expires 2028-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,093 | $33.02 Strike: $33.02 | $36,090.86 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 17 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,912 Underlying: Common Stock · 1,093 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 157 | $33.63 Strike: $33.63 | $5,279.91 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 16 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 837 Underlying: Common Stock · 157 shares Expires 2028-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
SaleCommon Stock | 1,402 | $59.54 | $83,472.00 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 12 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,200 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F7 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.71 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionCommon Stock | 1,402 | $33.63 | $47,149.26 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 11 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
SaleCommon Stock | 1,093 | $59.53 | $65,068.48 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 10 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,200 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionCommon Stock | 1,093 | $33.02 | $36,090.86 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 9 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
SaleCommon Stock | 157 | $59.52 | $9,344.18 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 8 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,200 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionCommon Stock | 157 | $33.63 | $5,279.91 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 7 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:05 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 100 | $59.66 | $5,966.00 |
DisclosureSEC source: 0001415889-23-008568 · form4-05232023_080529.xml · nonDerivative · entry 3 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,553 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:05 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 1,913 | $58.98 | $112,825.49 |
DisclosureSEC source: 0001415889-23-008568 · form4-05232023_080529.xml · nonDerivative · entry 2 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,653 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.61 to $59.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,948 | $33.63 Strike: $33.63 | $132,771.24 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 15 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,052 Underlying: Common Stock · 3,948 shares Expires 2028-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,995 | $33.02 Strike: $33.02 | $98,894.90 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 14 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,005 Underlying: Common Stock · 2,995 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 173 | $33.63 Strike: $33.63 | $5,817.99 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 13 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 994 Underlying: Common Stock · 173 shares Expires 2028-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
SaleCommon Stock | 3,948 | $59.53 | $235,029.57 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 6 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,200 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionCommon Stock | 3,948 | $33.63 | $132,771.24 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 5 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
SaleCommon Stock | 2,995 | $59.53 | $178,302.83 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 4 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,200 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionCommon Stock | 2,995 | $33.02 | $98,894.90 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 3 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
SaleCommon Stock | 173 | $59.52 | $10,297.69 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 2 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,200 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:12 UTC |
Reeve EmmaDirector
|
Exercise / conversionCommon Stock | 173 | $33.63 | $5,817.99 |
DisclosureSEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 1 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:05 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 6,403 | $58.96 | $377,490.79 |
DisclosureSEC source: 0001415889-23-008568 · form4-05232023_080529.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,566 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.50 to $59.42 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:04 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 788 | $58.71 | $46,266.87 |
DisclosureSEC source: 0001415889-23-008390 · form4-05192023_080525.xml · nonDerivative · entry 3 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,969 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.50 to $59.16 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.